Inovalon Holdings Company Profile (NASDAQ:INOV)

About Inovalon Holdings (NASDAQ:INOV)

Inovalon Holdings logoInovalon Holdings, Inc. (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. The Company serves clients across the healthcare industry, which includes health plans and provider organizations, pharmaceutical, medical device, and diagnostics companies. It provides technology that supports approximately 500 healthcare organizations. Inovalon's platforms are informed by data pertaining to more than 848,000 physicians, 371,000 clinical facilities, and more than 150 million Americans.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Healthcare Information Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:INOV
  • CUSIP: N/A
  • Web:
  • Market Cap: $1.98 billion
  • Outstanding Shares: 145,988,000
Average Prices:
  • 50 Day Moving Avg: $12.66
  • 200 Day Moving Avg: $12.34
  • 52 Week Range: $8.60 - $20.05
  • Trailing P/E Ratio: 74.86
  • Foreward P/E Ratio: 37.64
  • P/E Growth: 5.60
Sales & Book Value:
  • Annual Revenue: $433.24 million
  • Price / Sales: 4.57
  • Book Value: $4.54 per share
  • Price / Book: 2.98
  • EBIDTA: $81.29 million
  • Net Margins: 9.37%
  • Return on Equity: 7.79%
  • Return on Assets: 5.24%
  • Debt-to-Equity Ratio: 0.33%
  • Current Ratio: 11.86%
  • Quick Ratio: 11.86%
  • Average Volume: 553,036 shs.
  • Beta: 1.14
  • Short Ratio: 11.79

Frequently Asked Questions for Inovalon Holdings (NASDAQ:INOV)

What is Inovalon Holdings' stock symbol?

Inovalon Holdings trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon Holdings' earnings last quarter?

Inovalon Holdings Inc (NASDAQ:INOV) posted its quarterly earnings data on Wednesday, May, 3rd. The company reported $0.05 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.05. The business earned $108.31 million during the quarter, compared to the consensus estimate of $102.05 million. Inovalon Holdings had a net margin of 9.37% and a return on equity of 7.79%. View Inovalon Holdings' Earnings History.

What guidance has Inovalon Holdings issued on next quarter's earnings?

Inovalon Holdings updated its FY17 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of $0.29-0.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.30. The company issued revenue guidance of $440.5-455.0 million, compared to the consensus revenue estimate of $444.86 million.

Where is Inovalon Holdings' stock going? Where will Inovalon Holdings' stock price be in 2017?

10 equities research analysts have issued 1-year target prices for Inovalon Holdings' stock. Their forecasts range from $10.00 to $20.00. On average, they expect Inovalon Holdings' share price to reach $15.38 in the next twelve months. View Analyst Ratings for Inovalon Holdings.

Are investors shorting Inovalon Holdings?

Inovalon Holdings saw a decrease in short interest in the month of April. As of April 28th, there was short interest totalling 9,190,591 shares, a decrease of 1.5% from the April 13th total of 9,334,886 shares. Based on an average daily trading volume, of 391,270 shares, the short-interest ratio is presently 23.5 days.

Who are some of Inovalon Holdings' key competitors?

When did Inovalon Holdings IPO?

(INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Who owns Inovalon Holdings stock?

Inovalon Holdings' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Black Creek Investment Management Inc. (6.69%), Vanguard Group Inc. (3.25%), Riverbridge Partners LLC (2.17%), FMR LLC (1.73%), Neuberger Berman Group LLC (1.31%) and Parametric Portfolio Associates LLC (0.78%). Company insiders that own Inovalon Holdings stock include Christopher E Greiner, Daniel L Rizzo, Joseph R Rostock, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, Shauna L Vernal, Thomas R Kloster, William D Green and William J Teuber Jr. View Institutional Ownership Trends for Inovalon Holdings.

Who sold Inovalon Holdings stock? Who is selling Inovalon Holdings stock?

Inovalon Holdings' stock was sold by a variety of institutional investors in the last quarter, including Trigran Investments Inc., Menta Capital LLC, Penn Davis Mcfarland Inc., Tocqueville Asset Management L.P., UBS Group AG, Clinton Group Inc., State of Wisconsin Investment Board and Tudor Investment Corp ET AL. Company insiders that have sold Inovalon Holdings stock in the last year include Daniel L Rizzo, Joseph R Rostock, Shauna L Vernal and Thomas R Kloster. View Insider Buying and Selling for Inovalon Holdings.

Who bought Inovalon Holdings stock? Who is buying Inovalon Holdings stock?

Inovalon Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Black Creek Investment Management Inc., Parametric Portfolio Associates LLC, Prentiss Smith & Co. Inc., First Quadrant L P CA, Cowen Prime Services LLC, Goldman Sachs Group Inc. and PNC Financial Services Group Inc.. Company insiders that have bought Inovalon Holdings stock in the last two years include Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, William D Green and William J Teuber Jr. View Insider Buying and Selling for Inovalon Holdings.

How do I buy Inovalon Holdings stock?

Shares of Inovalon Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Inovalon Holdings stock cost?

One share of Inovalon Holdings stock can currently be purchased for approximately $13.55.

Analyst Ratings

Consensus Ratings for Inovalon Holdings (NASDAQ:INOV) (?)
Ratings Breakdown: 2 Sell Ratings, 6 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $15.38 (13.47% upside)

Analysts' Ratings History for Inovalon Holdings (NASDAQ:INOV)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/23/2017William BlairReiterated RatingMarket PerformN/AView Rating Details
2/13/2017Bank of America CorpDowngradeNeutral -> Underperform$10.00N/AView Rating Details
12/13/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
12/4/2016Pacific CrestSet Price TargetBuy$20.00N/AView Rating Details
10/24/2016First AnalysisInitiated CoverageEqual -> Equal Weight$14.00N/AView Rating Details
9/23/2016Robert W. BairdLower Price TargetNeutral$15.00 -> $14.00N/AView Rating Details
8/16/2016KeyCorpLower Price TargetOverweight$26.00 -> $20.00N/AView Rating Details
8/4/2016Citigroup IncLower Price TargetNeutral$18.00 -> $17.00N/AView Rating Details
8/4/2016Goldman Sachs Group IncDowngradeBuy -> Neutral$25.00 -> $17.00N/AView Rating Details
8/4/2016Piper Jaffray CompaniesDowngradeNeutral -> Underweight$14.00 -> $11.00N/AView Rating Details
5/8/2016Morgan StanleyReiterated RatingSell$16.00N/AView Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Inovalon Holdings (NASDAQ:INOV)
Earnings by Quarter for Inovalon Holdings (NASDAQ:INOV)
Earnings History by Quarter for Inovalon Holdings (NASDAQ:INOV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1 2017$0.05$0.05$102.05 million$108.31 millionViewListenView Earnings Details
2/22/2017Q4 2016$0.03$0.05$95.10 million$96.09 millionViewListenView Earnings Details
11/2/2016Q316$0.06$0.10$102.38 million$105.01 millionViewListenView Earnings Details
8/3/2016Q2$0.14$0.14$126.86 million$123.80 millionViewListenView Earnings Details
5/4/2016Q116$0.08$0.05$97.96 million$102.70 millionViewN/AView Earnings Details
2/25/2016Q4$0.13$0.13$125.40 million$120.60 millionViewListenView Earnings Details
11/4/2015Q315$0.09$0.09$102.76 million$105.46 millionViewN/AView Earnings Details
8/5/2015Q215$0.18$0.17$122.06 million$117.62 millionViewListenView Earnings Details
5/6/2015Q115$0.09$0.11$91.00 million$93.60 millionViewListenView Earnings Details
3/25/2015Q414$0.11$0.11$89.20 million$89.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Inovalon Holdings (NASDAQ:INOV)
2017 EPS Consensus Estimate: $0.31
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.01$0.04$0.03
Q2 20172$0.06$0.06$0.06
Q3 20173$0.08$0.17$0.11
Q4 20173$0.07$0.20$0.12
(Data provided by Zacks Investment Research)


Dividend History for Inovalon Holdings (NASDAQ:INOV)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Inovalon Holdings (NASDAQ:INOV)
Insider Ownership Percentage: 50.71%
Institutional Ownership Percentage: 28.75%
Insider Trades by Quarter for Inovalon Holdings (NASDAQ:INOV)
Institutional Ownership by Quarter for Inovalon Holdings (NASDAQ:INOV)
Insider Trades by Quarter for Inovalon Holdings (NASDAQ:INOV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2017Shauna L VernalInsiderSell19,332$13.60$262,915.20View SEC Filing  
5/8/2017Joseph R RostockInsiderSell104,649$13.07$1,367,762.43View SEC Filing  
5/5/2017Keith R DunleavyCEOBuy40,000$12.98$519,200.00View SEC Filing  
12/16/2016Robert A WychulisPresidentBuy1,675$9.29$15,560.75View SEC Filing  
12/16/2016William D GreenDirectorBuy30,000$9.29$278,700.00View SEC Filing  
12/14/2016Keith R DunleavyCEOBuy100,000$9.21$921,000.00View SEC Filing  
11/11/2016Thomas R KlosterCFOSell109,899$15.53$1,706,731.47View SEC Filing  
9/16/2016William D GreenDirectorBuy30,000$16.22$486,600.00View SEC Filing  
9/8/2016William J Teuber JrDirectorBuy60,000$16.46$987,600.00View SEC Filing  
7/12/2016Daniel L RizzoInsiderSell43,577$20.02$872,411.54View SEC Filing  
5/9/2016Keith R DunleavyCEOBuy30,000$16.68$500,400.00View SEC Filing  
3/4/2016Robert A WychulisPresidentSell33,003$18.17$599,664.51View SEC Filing  
12/9/2015Daniel L RizzoInsiderSell24,000$20.00$480,000.00View SEC Filing  
12/4/2015Shauna L. VernalinsiderSell33,437$18.55$620,256.35View SEC Filing  
8/28/2015Christopher E. GreinerCOOSell124,813$21.20$2,646,035.60View SEC Filing  
8/28/2015Keith R. DunleavyCEOBuy50,000$21.30$1,065,000.00View SEC Filing  
8/27/2015Lee D. RobertsDirectorBuy24,000$21.05$505,200.00View SEC Filing  
2/18/2015Shauna L VernalInsiderBuy10,000$27.00$270,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Inovalon Holdings (NASDAQ:INOV)
Latest Headlines for Inovalon Holdings (NASDAQ:INOV)
DateHeadline logoInovalon Holdings Inc (INOV) Insider Shauna L. Vernal Sells 19,332 Shares - May 24 at 8:04 PM logoVanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical Industries, ... - May 17 at 9:57 AM logoShort Interest in Inovalon Holdings Inc (INOV) Drops By 1.5% - May 12 at 7:22 AM logoJoseph R. Rostock Sells 104,649 Shares of Inovalon Holdings Inc (INOV) Stock - May 9 at 4:37 PM logoInovalon Holdings Inc (INOV) Receives Consensus Recommendation of "Hold" from Analysts - May 9 at 9:25 AM logoKeith R. Dunleavy Buys 40,000 Shares of Inovalon Holdings Inc (INOV) Stock - May 8 at 1:40 PM logoKeyCorp Weighs in on Inovalon Holdings Inc's FY2018 Earnings (INOV) - May 8 at 11:56 AM logoQ2 2017 Earnings Forecast for Inovalon Holdings Inc Issued By William Blair (INOV) - May 8 at 8:15 AM logoInovalon Holdings Inc (INOV) Downgraded by Zacks Investment Research to "Hold" - May 6 at 12:36 AM logoInovalon Holdings Inc (INOV) Downgraded to Hold at Zacks Investment Research - May 6 at 12:32 AM logo$110.65 Million in Sales Expected for Inovalon Holdings Inc (INOV) This Quarter - May 5 at 3:14 PM logoEdited Transcript of INOV earnings conference call or presentation 3-May-17 9:00pm GMT - May 4 at 8:17 AM logoInovalon Holdings beats Street 1Q forecasts - May 4 at 8:17 AM logoInovalon Holdings Inc (INOV) Issues FY17 Earnings Guidance - May 4 at 1:12 AM logoInvestor Network: Inovalon Holdings, Inc. to Host Earnings Call - May 4 at 12:46 AM logoInovalon Reports First Quarter 2017 Results - May 4 at 12:46 AM logoInovalon Holdings Inc (INOV) Updates FY17 Earnings Guidance - May 3 at 9:24 PM logoInovalon Holdings Inc (INOV) Expected to Announce Earnings of $0.03 Per Share - May 3 at 2:10 PM logoInovalon Holdings (INOV) Receiving Favorable News Coverage, Report Shows - May 2 at 10:34 PM logoInovalon Holdings, Inc. – Value Analysis (NASDAQ:INOV) : April 28, 2017 - April 28 at 6:55 PM logoInovalon Holdings (INOV) Earns News Sentiment Score of 0.57 - April 28 at 7:44 AM logoInovalon Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INOV-US : April 27, 2017 - April 27 at 6:30 PM logoInovalon Announces First Quarter 2017 Earnings Conference Call - April 19 at 11:23 AM logoZacks: Brokerages Expect Inovalon Holdings Inc (INOV) Will Post Quarterly Sales of $102.05 Million - April 14 at 1:57 PM logoInovalon Holdings (INOV) Earns Daily Media Impact Rating of 0.23 - April 14 at 12:46 PM logoInovalon Holdings Inc (INOV) Given Consensus Recommendation of "Hold" by Analysts - April 14 at 10:41 AM logoInovalon Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INOV-US : April 14, 2017 - April 14 at 9:23 AM logoINOVALON HOLDINGS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Pr - April 3 at 5:01 PM logoBRIEF-Amgen enters into agreement with Inovalon and Avalere - March 29 at 6:26 PM logoAmgen Enters Into Agreement With Inovalon and Avalere to Engage Value-Based Contracting Opportunities - March 29 at 10:33 AM logoInovalon Holdings Inc (INOV) Upgraded by Zacks Investment Research to Hold - March 26 at 6:00 PM logoInovalon Holdings Inc (INOV) Given Average Recommendation of "Hold" by Brokerages - March 20 at 1:22 PM logoWhy Inovalon Holdings (INOV) Could Be Positioned for a Surge - March 15 at 6:14 PM logoResearch Reports Initiation on Healthcare Information Services ... - PR Newswire (press release) - March 14 at 5:06 PM logoInovalon Holdings, Inc. Announces Date of Its 2017 Annual Meeting ... - Nasdaq - March 14 at 5:06 PM logoInovalon Holdings, Inc. Announces Date of Its 2017 Annual Meeting of Stockholders - March 14 at 11:51 AM logoINOVALON HOLDINGS, INC. Financials - March 1 at 5:36 PM logoBRIEF-Inovalon Q4 non-GAAP earnings per share $0.05 - February 22 at 6:10 PM logoInovalon Reports Fourth Quarter and Full Year 2016 Results - February 22 at 6:10 PM logo4:15 pm Inovalon beats by $0.02, beats on revs; guides FY17 EPS slightly below consensus, revs in-line - February 22 at 6:10 PM logoINOVALON HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, - February 22 at 6:10 PM logoInovalon Holdings Inc Earnings Call scheduled for 5:00 pm ET today - February 22 at 6:10 PM logoInovalon downgraded by BofA/Merrill - February 13 at 11:58 PM logoForm SC 13G/A Inovalon Holdings, Inc. Filed by: VANGUARD SPECIALIZED FUNDS - - February 13 at 6:57 PM logoForm SC 13G/A Inovalon Holdings, Inc. Filed by: VANGUARD SPECIALIZED FUNDS - February 13 at 11:11 AM logoInovalon Announces Agreement With Boehringer Ingelheim to Support Outcome-Based Contracting - January 31 at 4:42 AM logoAI Firm Afiniti Said to Weigh IPO at About $2 Billion Value - January 24 at 6:40 PM logo7:56 am Inovalon announces agreement with Boehringer Ingelheim Pharmaceuticals, subsidiary of Eli Lilly (LLY) - January 23 at 10:51 AM



Inovalon Holdings (INOV) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by Staff